CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $570,958 | -14.5% | 26,360 | -19.8% | 0.01% | 0.0% |
| Q4 2022 | $667,630 | +39.7% | 32,872 | +76.4% | 0.01% | +50.0% |
| Q3 2022 | $478,000 | -41.4% | 18,631 | -49.8% | 0.00% | -42.9% |
| Q2 2021 | $816,000 | -7.6% | 37,100 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $883,000 | -39.4% | 37,100 | -33.4% | 0.01% | -38.5% |
| Q4 2020 | $1,457,000 | -51.5% | 55,700 | -67.7% | 0.01% | -59.4% |
| Q3 2020 | $3,002,000 | -3.6% | 172,500 | -6.9% | 0.03% | -13.5% |
| Q2 2020 | $3,115,000 | +33.1% | 185,200 | -4.3% | 0.04% | +85.0% |
| Q4 2019 | $2,341,000 | +118.0% | 193,500 | +154.6% | 0.02% | +100.0% |
| Q3 2019 | $1,074,000 | +145.2% | 76,000 | +234.8% | 0.01% | +150.0% |
| Q3 2017 | $438,000 | +63.4% | 22,700 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $268,000 | -46.5% | 22,700 | -50.3% | 0.00% | -25.0% |
| Q1 2017 | $501,000 | – | 45,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |